October 29, 2026
Egg Donation Risks for Recipients: What the Research Shows, How Clinics Screen Donors & When to Ask Questions

If you are exploring donor eggs as a path to parenthood, it is natural to want a clear picture of the risks involved, not just the possibilities. Most of what you will find online about egg donation risk is written for the donor, covering the retrieval procedure itself. That is a different question from the one you are actually asking: what does using donor eggs mean for you, for your pregnancy, and for the child you hope to have. This article addresses that recipient-side question directly, walking through what the research says, how reputable donor egg programs screen for risk before you ever see a donor profile, and the questions worth asking any clinic or donor bank before you move forward.

Clarifying: Risks for Recipients vs. Risks for Donors

Egg donation involves two people whose experiences and risk profiles are entirely separate. The donor undergoes ovarian stimulation and an egg retrieval procedure, and the physical risks associated with that process, such as ovarian hyperstimulation, belong to her medical experience, not yours. As the intended parent, your risk considerations sit on a different side of the process entirely: they relate to the genetic and medical screening the donor underwent before her eggs were ever made available, the fertility treatment you will undergo to achieve pregnancy, and the pregnancy itself.

This distinction matters because a lot of search results and forum discussions blend the two together under a single label of "egg donation risk," which can leave intended parents more anxious than the facts warrant. When you are evaluating a donor egg bank or agency, the more useful question is not "is egg donation risky" in the abstract, but "how thoroughly has this donor been screened, and what does that mean for my outcome." That is the lens this page uses throughout.

It also matters because the two sets of risks call for different conversations with different people. Questions about a donor's physical experience during retrieval belong with the donor's own medical team, and a reputable program will not ask you to manage or worry about that side of the process on her behalf. Your conversations, by contrast, belong with your own reproductive endocrinologist and with the donor egg bank's screening and support staff, focused on what has already been verified about the donor and what your treatment plan involves from here.

Keeping these two tracks separate also helps you ask sharper questions. Instead of a broad "is this safe," you can ask specifically about screening scope, documentation, and how your clinic plans to structure your embryo transfer, which are the factors that are actually within your control as a recipient.

What the Research Says About Recipient-Side Considerations

Reproductive medicine researchers and organizations such as the American Society for Reproductive Medicine (ASRM) have studied donor egg outcomes for decades, and the recipient-side considerations they highlight generally fall into three categories.

The first is genetic risk. Every donor carries some genetic variants, as every person does, which is why reputable programs perform genetic carrier screening before a donor is approved. This screening is designed to identify whether a donor carries genes for specific inherited conditions so that, combined with information about the intended father or sperm donor, the likelihood of passing on a serious inherited condition can be meaningfully reduced. No screening process can eliminate genetic risk entirely, since medicine cannot test for every possible condition, but a thorough carrier screening panel substantially narrows the field of concern compared with conception without any screening at all.

The second is infectious disease risk. Donor eggs and the donors who provide them are subject to infectious disease testing requirements set by the FDA and reinforced by ASRM guidance, covering conditions that could otherwise be transmitted through donated reproductive tissue. This testing is a standard, non-negotiable part of any legitimate donor egg program.

The third consideration is not about the donor at all, but about how many embryos are transferred during your treatment. Transferring more than one embryo increases the chance of a multiple pregnancy, which carries its own set of obstetric considerations regardless of whether the eggs came from a donor or from the intended mother. This is a conversation to have directly with your fertility clinic, since embryo transfer decisions are made collaboratively between you and your reproductive endocrinologist based on your specific medical picture.

It is also worth noting what the research does not show. In other words, much of what determines your pregnancy experience relates to your own medical picture and your clinic's transfer protocol, not to the fact that the eggs came from a donor.

Your fertility clinic is best positioned to walk you through numbers that reflect your own treatment plan, and any numbers you do see should be confirmed with your physician before you rely on them.

How Donor Screening Reduces Risk

The reason donor egg programs can offer intended parents meaningful reassurance is not that risk disappears, but that a rigorous screening process is designed to identify and reduce it well before a donor is ever matched with a family. A thorough screening protocol typically includes several layers.

Genetic carrier screening. Donors are tested against an expanded panel of inherited conditions, and the results are documented and made available for your own physician's review as part of your treatment planning.

Psychological evaluation. A licensed mental health professional evaluates each prospective donor to assess her understanding of the donation process, her motivations, and her readiness, which supports both her wellbeing and the stability of the program overall.

Infectious disease testing. The FDA requires donors to be tested for infectious disease markers within 30 days of egg retrieval, and this testing is repeated on a schedule consistent with regulatory guidance.

Medical history review. A detailed personal and family medical history is collected and reviewed, giving your physician additional context beyond the genetic panel alone, including patterns that might not show up on a standard carrier screen.

Together, these layers are why working with a donor egg bank that takes screening seriously is one of the most direct ways to address recipient-side risk. None of this replaces a conversation with your own reproductive endocrinologist, but it does mean that by the time you are reviewing a donor's profile through donor search, a substantial amount of risk-reduction work has already taken place.

Questions to Ask Your Clinic or Donor Bank

Whether you are working with Lotus Donor Bank or evaluating another program, it is reasonable to ask direct questions before selecting a donor. Consider bringing the following to your next conversation with your clinic or donor coordinator.

What screening was performed on this donor, and when? Ask for specifics rather than a general assurance, including the name of the genetic panel used and the date of the donor's most recent infectious disease testing.

What genetic conditions were included in the screening panel? Panels vary in scope, and understanding what was and was not tested helps you and your physician assess whether any additional testing makes sense for your family.

What happens if a screening concern is identified? Ask how the program handles a donor whose results raise a flag, including whether and how that information is disclosed and what your options are as the intended parent.

How many embryos does my clinic recommend transferring, and why? This is a question for your reproductive endocrinologist specifically, since it depends on your embryo quality, your health history, and your own preferences around multiple pregnancy.

Can I review the donor's documented history directly? A program confident in its screening process should be able to walk you through a donor's documentation, not simply tell you that screening occurred.

How Lotus Approaches Donor Screening

Lotus Donor Bank built its screening approach around the idea that intended parents deserve clarity, not just reassurance. Every donor who becomes part of the Lotus network goes through genetic carrier screening, a psychological evaluation with a licensed professional, infectious disease testing consistent with FDA guidance, a urine drug screen, and a documented medical history review, before her profile is ever made available through donor search.

Lotus also works with a broad range of donor backgrounds, including Caucasian, African-American, Middle Eastern, Hispanic/Latina, Jewish Heritage, Asian, Indian, Hawaiian/Pacific Islander and more, reflecting the reality that families come from every community and deserve a donor pool that does the same. Whether you are drawn to a fresh donor egg cycle or a frozen donor egg lot, the same screening standards apply, and the donor matching process is designed to keep you informed at every step rather than leaving you to guess at what has already been verified.

If a question comes up that is not answered here, or if you want to talk through what screening looks like for a specific donor you are considering, the Lotus team is available to walk through it with you directly.

Frequently Asked Questions

Are there health risks for recipients when using donor eggs?

The physical risks of the egg retrieval procedure itself belong to the donor, not the recipient. As an intended parent, your considerations center on the thoroughness of the donor's genetic and medical screening, the specifics of your own fertility treatment, and standard pregnancy considerations such as the number of embryos transferred. Your reproductive endocrinologist is the best source for how these factors apply to your specific treatment plan.

How does genetic screening reduce risk for donor-conceived children?

Genetic carrier screening tests a donor against a panel of known inherited conditions. When that information is combined with genetic information about the intended father or sperm donor, it allows your medical team to assess and substantially reduce, though not entirely eliminate, the likelihood of passing on a serious inherited condition.

What is screened for before a donor is approved?

A thorough donor screening protocol typically includes expanded genetic carrier testing, a psychological evaluation conducted by a licensed mental health professional, infectious disease testing in line with FDA requirements, and a detailed personal and family medical history review.

Does using donor eggs increase the risk of multiples?

Using donor eggs itself does not increase multiple-pregnancy risk. That risk is tied to how many embryos are transferred during your treatment cycle, which is a decision made with your fertility clinic based on embryo quality and your individual medical circumstances, regardless of whether the eggs are your own or donated.

What questions should I ask before choosing a donor?

Ask what specific screening the donor completed and when, what genetic conditions were included in her testing panel, how the program handles any flagged concerns, and whether you can review her documented history directly with your clinic or donor coordinator.

Have Questions About Screening and Safety?

Choosing a donor is one of the most significant decisions in your family-building journey, and you should feel fully informed before you make it. If you have questions about how donor screening works, what a specific donor's documentation includes, or how the process moves from donor search to matching, speak with our team before making your donor selection. We are here to walk through the details with you, not just point you toward a profile.